BeOne

DPHARM panel
CRO

DPHARM: How to address the clinical trial enrollment crisis?

Around 80% of trials don’t meet their enrollment timelines, and fewer than 5% of eligible adult cancer patients participate in trials.
Will Maddox Sep 17, 2026 11:52am
ASCO
Favicon Fierce Pharma

Akeso's 34% overall survival win comes with caveats

May 31, 2026 8:00am
pipeline pipes RD research

BeOne shelves 5 cancer programs, halts ph. 2 arthritis trial

May 7, 2026 11:15am
A ballpoint pen rests on top of a stack of documents ready for signing

BeOne signs $2B deal for option on preclinical trispecific

Apr 30, 2026 7:55am
Jefferies London 2025 entrance

Jefferies London conference earns reputation as 'JPM for Europe'

Nov 18, 2025 10:00am
Akeso
Favicon Fierce Pharma

Akeso, Summit's ivonescimab ups PD-1 in chemo combo in 1L NSCLC

Oct 19, 2025 10:45am